• Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management

  • Sep 23 2024
  • Length: 18 mins
  • Podcast

Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management

Listen for free

View show details

  • Summary

  • CJASN editors highlight three articles centered on the theme of CKD, including articles on SGLT2 inhibitors in CKD patients; SGLT2 inhibitors and cardiovascular death in CKD; and smartphone intervention for lifestyle and hypertension management in CKD.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available